Spray Reagents for the Thin Layer Chromatography of Drug Extracts

Total Page:16

File Type:pdf, Size:1020Kb

Spray Reagents for the Thin Layer Chromatography of Drug Extracts Spray Reagents For the thin layer chromatography of drug extracts No. 1 Anisaldehyde-acetic acid reagent (AA) 0.5 ml Anisaldehyde mixed with 10 ml of 98% acetic acid. The TLC plate is sprayed with 5-10 ml, then heated at 120 0 C for 7-10 min in a drying cabinet. Detection 0/ petasin/isopetasin. The plate may be sprayed afterwards with conc. sulphuric acid and evaluated in vis. or UV-365 nm. NO.2 Anisaldehyde-sulphuric acid reagent (AS) 0.5 ml Anisaldehyde is mixed with 10 ml glacial acetic acid, followed by 85 ml metha­ nol and 5 ml concetrated sulphuric acid, in that order. The re agent has only limited stability, and is no longer useable when the colour has turned to red-violet. The TLC plate is sprayed with ab out 10 ml, heated at 100° C for 5-10 min, then evaluated in vis. or UV-365 nm. Detection 0/ essential oils, pungent principles, bitter principles, saponins, etc. NO.3 Antimony(lII) chloride reagent (SbCI 3) 20% solution of antimony(III) chloride in chloroform. The TLC plate must be sprayed with 15-20 ml reagent, then heated for 5-6 min at 100° C. Evaluation in vis. or UV-365 nm. Detection 0/ cardiac glycosides, saponins, visnagin (Ammi visnagae /ructus), etc. NO.4 Benzidine re agent (BZ) 0.5 g Benzidine is dissolved in 10 ml glacial acetic acid and the volume adjusted to 100 ml with ethanol. Evaluation in vis. Detection 0/ aucubin (Plantaginis folium) NO.5 Berlin blue reagent (BB) A freshly prepared solution of 10 g iron(III) chloride and 0.5 g potassium hexacyano­ ferrate in 100 ml water. The plate is sprayed with 5-8 ml and evaluated in vis. Detection 0/ arbutin. NO.6 Blood reagent (BL) 10 ml of 3.6% sodium citrate are added to 90 ml fresh bovine blood. 2 ml of this mixture are mixed with 30 ml phosphate buffer pH 7.4*. The plate is sprayed in a horizontal position. * Phosphate buffer pH 7.4 25.00 ml potassium dihydrogen phosphate solution (27.281 g potassium dihydrogen phosphate dissolved in CO2 -free water (double distilled) and volume adjusted to 1,000 ml) mixed with 39.34 ml of 0.1 M sodium hydroxide, and volume made up to 100 ml with CO2 -free, double distilled water. Detection 0/ saponins; white zones are formed against the reddish background of the plate. Haemolysis may be immediate, or it may not occur until the plate has been warmed. Boroxyl reagent. See Natural products-polyethyleneglycol reagent No. 28. 299 NO.7 Chloramine-trichloroacetic acid reagent (CTA) 10 ml freshly prepared 3% aqueous chloramine T solution (syn. sodium sulphamide chloride, or sodium tosy1chloramide) is mixed with 40 ml of 25% ethanolic trichloro­ acetic acid. The plate is sprayed with 10-15 ml, heated at 100° C for 5-10 min and evaluated in UV-365 nm. Detection of cardiac glycosides. NO.8 Dichloroquinonechloroimide reagent (DCC) 1 % methanolic solution of 2,6-dichloroquinonechloroimide. The plate is sprayed with 5-10 ml, then immediately exposed to ammonia vapour. Detection of arbutin (DAB 8), capsaicin (DAB 8). NO.9 Dinitrophenylhydrazine reagent (DNPH) 0.1 g of 2,4-dinitrophenylhydrazine is dissolved in 100 ml methanol, followed by the addition of 1 ml of 36% hydrochloric acid. After spraying with about 10 ml, the plate is evaluated immediately in vis. Detection of ketones and aldehydes. No. 10 DNPH-acetic acid-hydrochloric acid reagent 0.2 g of 2,4-dinitrophenylhydrazine in a solvent mixture consisting of 40 ml 98% acetic acid, 40 ml 25% hydrochloric acid and 20 ml methanol. The plate is sprayed with 10 ml and evaluated in vis. It is then heated at 100° C for 5-10 min and evaluated again in vis. (Ph. Eur. III). Detection of valepotriates (Valerianae radix). Chromogenic dien es react without warming. Remarks: Dienes can also be detected with HCL-AA reagent (No. 32). No. 11 Dragendorffreagents (DRG) Detection of alkaloids, heterocyclic nitrogen compounds, quarternary amines. No. 11A Dragendorffreagent (Ph. Eur. I, p. 139) 0.85 g basic bismuth nitrate is dissolved in 40 ml water and 10 ml glacial acetic acid, followed by addition of 8 g potassium iodide dissolved in 20 ml water. No. 11 B Dragendorff reagent Rl (Ph. Eur. III, p. 105) 100 g tartaric acid are dissolved in 400 ml water. 8.5 g basic bismuth nitrate are added and the solution is shaken for 2 h. 200 ml of 40% potassium iodide are then added, and the solution is shaken vigorously. After standing 24 h, the solution is filtered. Diluted Dragendorff reagent (Ph. Eur. III, p. 105) 50 ml Dragendorff reagent Rl are added to a solution of 100 g tartaric acid in 500 ml water. No. 11 C Dragendorff reagent with tartaric acid Solution A: 17 g bismuth subnitrate and 200 g tartaric acid in 800 ml water. Solution B: 160 g potassium iodide in 400 ml water. A + B = stock solution Spray reagent: 50 ml stock solution + 500 ml water + 100 g tartaric acid. No. 11 D Dragendorff reagent with hydrochloric acid (modified) Solution A: 0.3 g bismuth sub nitrate, 1 ml of 25% HCl, 5 ml water. Solution B: 3 g potassium iodide in 5 ml water. Spray reagent: 5 ml A + 5 ml B + 5 ml of 12.5% HCI + 100 ml water. 300 No. HE Dragendorffreagent according to Vaguifalvi A mixture of 2.6 g bismuth carbonate, 7 g dried sodium iodide and 25 ml glacial acetic acid is heated to boiling for a few minutes. After standing overnight, the precipitated sodium acetate is removed by filtration. 20 ml of the c1ear red filtrate are mixed with 80 ml ethyl acetate to give the stock solution. Spray reagent: 2 ml stock solution, 5 ml glacial acetic and and 12 ml ethyl acetate. Detection limit: approx. 1 Ilg. After the plate has been dried (i.e. the smell of acetic acid is no longer detectable), it can be sprayed again with 5% ethanolic sulphuric acid, ihereby giving a ten-fold increase in sensitivity. No. HF Dragendorffreagent,Jollowed by sodium nitrite or H Z S04 After treatment with any type of Dragendorff reagent, the plate may be additionally sprayed with 5% aqueous sodium nitrite or with 5% ethanolic sulphuric acid, thereby intensifying the coloured zones. No. 12 Fast blue salt reagent (FBS) 0.5 g fast blue salt B is dissolved in 100 ml water. (Fast blue salt B=3,3'-dimethoxy­ biphenyl-4-4' -bise diazonium)-dichloride) The plate is sprayed with 6-8 ml, dried and inspected in vis. Spraying may be repeated, using 0.1 M NaOH, followed again by inspection in vis. Detection of bitter principles /rom hops, and phenolic compounds in general. No. 13 Fast red salt reagent (FRS) 0.5% aqueous solution of fast red salt B (=diazotized 5-nitro-2-aminoanisole). The plate is sprayed with 10 ml, followed immediately by either 0.1 M NaOH or exposure to ammonia vapour. Detection 0/ amarogentin. No. 14 Iron(III) chloride reagent (FeCI3) 10% aqueous solution. Spray with 5-10 ml and evaluate in vis. Detection %leuropein; carnosolic acid (Salviae folium, Rosmarini folium); hop bitter principles. No. 15 EP reagent according to Stahl (EP) 0.25 g of 4-dimethylaminobenzaldehyde is dissolved in a mixture of 45 ml of 98% acetic acid, 5 ml of 85% o-phosphoric acid and 45 ml water, followed by 50 ml conc. sulphuric acid with cooling. The sprayed plate is evaluated immediately in vis., or after heating. Detection 0/ azulenes (Matricariae flos) ; the natural blue of the azulenes is intensified by EP reagent. After warming at 100° C for 3-5 min, proazulene gives a blue-green (vis.). No. 16 Acetic anhydride-sulphuric acid reagent Liebermann-Burchard reagent (LB) 5 ml acetic anhydride and 5 ml conc. sulphuric acid are added carefully to 50 ml absolute ethanol, while cooling in ice. The reagent must be freshly prepared. The sprayed plate is warmed at 100° C for 5-10 min, then inspected in UV- 365 nm. Detection oftriterpenes, steroids (saponins, bitter principles). No. 17 Iodine-chloroform reagent (I/CHCI3) 0.5% Iodine in chloroform. 301 The sprayed plate is warmed at 60° C for ab out 5 min. It may be evaluated immediately, or after standing for 10 min at room temperature. Detection o/Ipecacuanha alkaloids. No. 18 Iodine re agent About 10 g solid iodine are spread on the bottom of a chromatography tank. Com­ pounds containing conjugated double bonds give yellow-brown (vis.) zones on expo­ sure to the atmosphere of iodine vapour. No. 19 Iodoplatinate re agent (IP) 0.3 g hydrogen hexachloroplatinate (IV) hydrate is dissolved in 100 ml water and mixed with 100 ml of 6% potassium iodide solution. The plate is sprayed with 10 ml and evaluated in vis. Detection o/nitrogen-containing compounds, e.g. alkaloids (blue-violet). For the detec­ tion of Cinchona alkaloids, the plate is first sprayed with 5% ethanolic H ZS04 (No. 34), and then with IP reagent. No.20 Iodine-hydrochloric aicd reagent (I/HCl) 1 g potassium iodide and 1 g iodine are dissolved in 100 ml ethanol (soln. I). 25 ml of 25% HCI are mixed with 25 ml of 96% ethanol (soln. Ir). The plate is first sprayed with 5 ml soln. 1, followed by 5 ml soln. Ir. Dark brown (vis.) zones are produced. Detection o/the purine derivatives, caffeine, theophylline and theobromine. No.21 Potassium hydroxide (KOH) 5% or 10% Ethanolic potassium hydroxide (Bornträger reaction) The plate is sprayed with 10 ml and evaluated in vis.
Recommended publications
  • Integrating Complementary Medicine Into Cardiovascular Medicine
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Journal of the American College of Cardiology Vol. 46, No. 1, 2005 © 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.031 ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT Integrating Complementary Medicine Into Cardiovascular Medicine A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) WRITING COMMITTEE MEMBERS JOHN H. K. VOGEL, MD, MACC, Chair STEVEN F. BOLLING, MD, FACC BRIAN OLSHANSKY, MD, FACC REBECCA B. COSTELLO, PHD KENNETH R. PELLETIER, MD(HC), PHD ERMINIA M. GUARNERI, MD, FACC CYNTHIA M. TRACY, MD, FACC MITCHELL W. KRUCOFF, MD, FACC, FCCP ROBERT A. VOGEL, MD, FACC JOHN C. LONGHURST, MD, PHD, FACC TASK FORCE MEMBERS ROBERT A. VOGEL, MD, FACC, Chair JONATHAN ABRAMS, MD, FACC SANJIV KAUL, MBBS, FACC JEFFREY L. ANDERSON, MD, FACC ROBERT C. LICHTENBERG, MD, FACC ERIC R. BATES, MD, FACC JONATHAN R. LINDNER, MD, FACC BRUCE R. BRODIE, MD, FACC* ROBERT A. O’ROURKE, MD, FACC† CINDY L. GRINES, MD, FACC GERALD M. POHOST, MD, FACC PETER G. DANIAS, MD, PHD, FACC* RICHARD S. SCHOFIELD, MD, FACC GABRIEL GREGORATOS, MD, FACC* SAMUEL J. SHUBROOKS, MD, FACC MARK A. HLATKY, MD, FACC CYNTHIA M. TRACY, MD, FACC* JUDITH S. HOCHMAN, MD, FACC* WILLIAM L. WINTERS, JR, MD, MACC* *Former members of Task Force; †Former chair of Task Force The recommendations set forth in this report are those of the Writing Committee and do not necessarily reflect the official position of the American College of Cardiology Foundation.
    [Show full text]
  • Thesis of Potentially Sweet Dihydrochalcone Glycosides
    University of Bath PHD The synthesis of potentially sweet dihydrochalcone glycosides. Noble, Christopher Michael Award date: 1974 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 05. Oct. 2021 THE SYNTHESIS OF POTBTTIALLY SWEET DIHYDROCHALCOITB GLYCOSIDES submitted by CHRISTOPHER MICHAEL NOBLE for the degree of Doctor of Philosophy of the University of Bath. 1974 COPYRIGHT Attention is drawn to the fact that copyright of this thesis rests with its author.This copy of the the­ sis has been supplied on condition that anyone who con­ sults it is understood to recognise that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be pub­ lished without the prior written consent of the author.
    [Show full text]
  • Treatment Protocol Copyright © 2018 Kostoff Et Al
    Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al PREVENTION AND REVERSAL OF ALZHEIMER'S DISEASE: TREATMENT PROTOCOL by Ronald N. Kostoffa, Alan L. Porterb, Henry. A. Buchtelc (a) Research Affiliate, School of Public Policy, Georgia Institute of Technology, USA (b) Professor Emeritus, School of Public Policy, Georgia Institute of Technology, USA (c) Associate Professor, Department of Psychiatry, University of Michigan, USA KEYWORDS Alzheimer's Disease; Dementia; Text Mining; Literature-Based Discovery; Information Technology; Treatments Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al CITATION TO MONOGRAPH Kostoff RN, Porter AL, Buchtel HA. Prevention and reversal of Alzheimer's disease: treatment protocol. Georgia Institute of Technology. 2018. PDF. https://smartech.gatech.edu/handle/1853/59311 COPYRIGHT AND CREATIVE COMMONS LICENSE COPYRIGHT Copyright © 2018 by Ronald N. Kostoff, Alan L. Porter, Henry A. Buchtel Printed in the United States of America; First Printing, 2018 CREATIVE COMMONS LICENSE This work can be copied and redistributed in any medium or format provided that credit is given to the original author. For more details on the CC BY license, see: http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License<http://creativecommons.org/licenses/by/4.0/>. DISCLAIMERS The views in this monograph are solely those of the authors, and do not represent the views of the Georgia Institute of Technology or the University of Michigan. This monograph is not intended as a substitute for the medical advice of physicians. The reader should regularly consult a physician in matters relating to his/her health and particularly with respect to any symptoms that may require diagnosis or medical attention.
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Allicin Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Up-Regulation of Claudin-4
    Zheng et al Tropical Journal of Pharmaceutical Research July 2014; 13 (7): 1063-1069 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v13i7.8 Original Research Article Allicin Protects against Lipopolysaccharide-Induced Acute Lung Injury by Up-Regulation of Claudin-4 Yue-liang Zheng, Wen-wei Cai, Guang-zhao Yan, Yuan-zhan Xu and Mei-qi Zhang* Department of Emergency, Zhejiang Provincial People's Hospital, Hangzhou 310014, China *For correspondence: Email: [email protected]; Tel: +86-0571-85893631 Received: 8 January 2014 Revised accepted: 31 May 2014 Abstract Purpose: To investigate the effect of allicin, an active component of garlic, on lipopolysaccharide (LPS)- induced acute lung injury. Methods: Wistar rats were subjected to LPS intravenous injection with or without allicin treatment to induce acute lung injury (ALI) model. Also, A549 cells were stimulated with LPS in the presence and absence of allicin. HE staining was used to detect pathological changes in lung tissues. Enzyme-linked immunosorbent assay (ELISA) was performed to measure cytokine content. Cell viability was measured by CCK-8 and EdU incorporation assay. Genes expression was determined by real time polymerase chain reaction (PCR) and Western blot. Flow cytometry was applied to measure cell apoptosis. Results: In vivo data showed that pulmonary edema, inflammatory cytokines expression and pathological changes were significantly attenuated in LPS-induced ALI after treatment with allicin (p < 0.05) while in vitro results indicate that allicin administration significantly improved the A549 cell viability in a dose-dependent manner as measured by CCK-8 and EdU incorporation assay.
    [Show full text]
  • In Chemistry, Glycosides Are Certain Molecules in Which a Sugar Part Is
    GLYCOSIDES Glycosides may be defined as the organic compounds from plants or animal sources, which on enzymatic or acid hydrolysis give one or more sugar moieties along with non- sugar moiety. Glycosides play numerous important roles in living organisms. Many plants store important chemicals in the form of inactive glycosides; if these chemicals are needed, the glycosides are brought in contact with water and an enzyme, and the sugar part is broken off, making the chemical available for use. Many such plant glycosides are used as medications. In animals (including humans), poisons are often bound to sugar molecules in order to remove them from the body. Formally, a glycoside is any molecule in which a sugar group is bonded through its carbon atom to another group via an O-glycosidic bond or an S-glycosidic bond; glycosides involving the latter are also called thioglycosides. The sugar group is then known as the glycone and the non-sugar group as the aglycone or genin part of the glycoside. The glycone can consist of a single sugar group (monosaccharide) or several sugar groups (oligosaccharide). Classification Classification based on linkages Based on the linkage of sugar moiety to aglycone part 1. O-Glycoside:-Here the sugar is combined with alcoholic or phenolic hydroxyl function of aglycone.eg:-digitalis. 2. N-glycosides:-Here nitrogen of amino group is condensed with a sugar ,eg- Nucleoside 3. S-glycoside:-Here sugar is combined with sulphur of aglycone,eg- isothiocyanate glycosides. 4. C-glycosides:-By condensation of a sugar with a cabon atom, eg-Cascaroside, aloin. Glycosides can be classified by the glycone, by the type of glycosidic bond, and by the aglycone.
    [Show full text]
  • Nine Traditional Chinese Herbal Formulas for the Treatment of Depression: an Ethnopharmacology, Phytochemistry, and Pharmacology Review
    Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Year: 2016 Volume: 12 Neuropsychiatric Disease and Treatment Dovepress Running head verso: Feng et al Running head recto: Chinese herbal formulas as antidepressants open access to scientific and medical research DOI: http://dx.doi.org/10.2147/NDT.S114560 Open Access Full Text Article REVIEW Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review Dan-dan Feng Abstract: Depression is a major mental disorder, and is currently recognized as the Tao Tang second-leading cause of disability worldwide. However, the therapeutic effect of antidepressants Xiang-ping Lin remains unsatisfactory. For centuries, Chinese herbal formulas (CHFs) have been widely used in Zhao-yu Yang the treatment of depression, achieving better therapeutic effects than placebo and having fewer Shu Yang side effects than conventional antidepressants. Here, we review the ethnopharmacology, phy- Zi-an Xia tochemistry, and pharmacology studies of nine common CHFs: “banxia houpo” decoction, “chaihu shugansan”, “ganmaidazao” decoction, “kaixinsan”, “shuganjieyu” capsules, “sinisan”, Yun Wang “wuling” capsules, “xiaoyaosan”, and “yueju”. Eight clinical trials and seven meta-analyses have Piao Zheng supported the theory that CHFs are effective treatments for depression, decreasing Hamilton Yang Wang Depression Scale scores and showing few adverse effects. Evidence from 75 preclinical studies Chun-hu Zhang has also elucidated the multitarget and multipathway mechanisms underlying the antidepres- Laboratory of Ethnopharmacology, sant effect of the nine CHFs. Decoctions, capsules, and pills all showed antidepressant effects, Institute of Integrated Traditional ranked in descending order of efficacy. According to traditional Chinese medicine theory, these Chinese and Western Medicine, Xiangya Hospital, Central South CHFs have flexible compatibility and mainly act by soothing the liver and relieving depression.
    [Show full text]
  • Glycosides in Lemon Fruit
    Food Sci. Technol. Int. Tokyo, 4 (1), 48-53, 1998 Characteristics of Antioxidative Flavonoid Glycosides in Lemon Fruit Yoshiaki MIYAKE,1 Kanefumi YAMAMOT0,1 Yasujiro MORIMITSU2 and Toshihiko OSAWA2 * Central Research Laboratory of Pokka Corporation, Ltd., 45-2 Kumanosyo, Shikatsu-cho, Nishikasugai-gun, Aichi 481, Japan 2Department of Applied Biological Sciences, Nagoya University, Nagoya 46401, Japan Received June 12, 1997; Accepted September 27, 1997 We investigated the antioxidative flavonoid glycosides in the peel extract of lemon fruit (Citrus limon). Six flavanon glycosides: eriocitrin, neoeriocitrin, narirutin, naringin, hesperidin, and neohesperidin, and three flavone glycosides: diosmin, 6~-di- C-p-glucosyldiosmin (DGD), and 6- C-p-glucosyldiosmin (GD) were identified by high- performance liquid chromatography (HPLC) analysis. Their antioxidative activity was examined using a linoleic acid autoxidation system. The antioxidative activity of eriocitrin, neoeriocitrin and DGD was stronger than that of the others. Flavonoid glycosides were present primarily in the peel of lemon fruit. There was only a small difference in the content of the flavonoid glycosides of the lemon fruit juice from various sources and varieties. Lemon fruit contained abundant amounts of eriocitrin and hesperidin and also contained narirutin, diosmin, and DGD, but GD, neoeriocitrin, naringin, and neohesperidin were present only in trace amounts. The content of DGD, GD, and eriocitrin was especially abundant in lemons and limes; however, they were scarcely found in other citrus fruits. The content of flavonoid compounds in lemon juice obtained by an in-line extractor at a juice factory was more abundant than that obtained by hand-squeezing. These compounds were found to be stable even under heat treatment conditions (121'C, 15 min) in acidic solution.
    [Show full text]
  • GRAS Notice (GRN) No. 719, Orange Pomace
    GRAS Notice (GRN) No. 719 https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/default.htm SAFETY EVALUATION DOSSIER SUPPORTING A GENERALLY RECOGNIZED AS SAFE (GRAS) CONCLUSION FOR ORANGE POMACE SUBMITTED BY: PepsiCo, Inc. 700 Anderson Hill Road Purchase, NY 10577 SUBMITTED TO: U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food Additive Safety HFS-200 5100 Paint Branch Parkway College Park, MD 20740-3835 CONTACT FOR TECHNICAL OR OTHER INFORMATION: Andrey Nikiforov, Ph.D. Toxicology Regulatory Services, Inc. 154 Hansen Road, Suite 201 Charlottesville, VA 22911 July 3, 2017 Table of Contents Part 1. SIGNED STATEMENTS AND CERTIFICATION ...........................................................1 A. Name and Address of Notifier .............................................................................................1 B. Name of GRAS Substance ...................................................................................................1 C. Intended Use and Consumer Exposure ................................................................................1 D. Basis for GRAS Conclusion ................................................................................................2 E. Availability of Information ..................................................................................................3 Part 2. IDENTITY, METHOD OF MANUFACTURE, SPECIFICATIONS, AND PHYSICAL OR TECHNICAL EFFECT.................................................................................................4
    [Show full text]
  • World Journal of Pharmaceutical Research Anjna Et Al
    World Journal of Pharmaceutical Research Anjna et al. World Journal of PharmaceuticalSJIF ImpactResearch Factor 8.074 Volume 8, Issue 10, 741-748. Research Article ISSN 2277– 7105 A PHYTOCHEMICAL STUDY OF ALLIUM SATIVUM – W.S.R TO ALLICIN CONTENT 1*Tak Anjna, 2Thakur Kumar Sudarshan and 3Das Kumar Arun 1Associate Professor, Prasuti Tantra Avum Stri Roga, Main Campus, Uttrakhanda Ayurveda University, Dehradun, Uttarakhanda. 2Lecturer, Ras Shashtra Avum Bhaishajya Kalpana, R.G.G.P.G. Ayurvedic College, Paprola, Himachal Pradesh. 3Principal, Professor & H.O.D, Ras Shashtra Avum Bhaishajya Kalpana, Govt. Ayurvedic College, Bolangir, Orisa. ABSTRACT Article Received on 15 July 2019, Allium sativum has attracted the interest of many researchers due to its Revised on 05 August 2019, wide range of therapeutic effects with minimal adverse reactions. Its Accepted on 25 August 2019, DOI: 10.20959/wjpr201910-15253 role in promoting the female reproductive health can be well understood from the fact Acharya Kashyap in his text has described a full chapter Lashuna Kalpadhyaya mentioning that the woman *Corresponding Author Tak Anjna consuming Lashuna will not suffer from diseases of kati, shroni Associate Professor, Prasuti (pelvis), gramyadharma janya rogas (sexually transmitted diseases) Tantra Avum Stri Roga, and infertility. Its effects are mainly attributed to its chemical Main Campus, Uttrakhanda constituents like Allicin, Ajoene and certain other sulphur compounds Ayurveda University, etc. In the present study, bulbs of Allium sativum were dried and in Dehradun, Uttarakhanda. controlled temperature and fine powder was made. It was filled in capsules and clinical trial was done in the patients of Hypomenorrhoea. In context of this, a phytochemical study of dried powder of Allium sativum was done and various chemical constituents of garlic have been investigated to support its pharmaco-therapeutic actions as per clinical study.
    [Show full text]
  • Pharmacy and Poisons Act 1979
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS ACT 1979 1979 : 26 TABLE OF CONTENTS PART I PRELIMINARY 1 Short title 2 Interpretation PART II THE PHARMACY COUNCIL 3 The Pharmacy Council 4 Membership of the Council 4A Functions of the Council 4B Protection from personal liability 4C Annual Report 5 Proceedings of the Council, etc PART III REGISTRATION OF PHARMACISTS 6 Offence to practise pharmacy if not registered 7 Registration as a pharmacist 7A Re-registration as non-practising member 7AA Period of validity of registration 8 Code of Conduct 9 Pharmacy Profession Complaints Committee 10 Investigation of complaint by Committee 10A Inquiry into complaint by Council 10B Inquiry by Council of its own initiative 11 Surrender of registration 12 Restoration of name to register 1 PHARMACY AND POISONS ACT 1979 13 Proof of registration 14 Appeals 14A Fees 14B Amendment of Seventh Schedule 15 Regulations for this part PART IV REGISTRATION OF PHARMACIES 16 Register of pharmacies 17 Registration of premises as registered pharmacies 18 Unfit premises: new applications 19 Unfit premises: registered pharmacies 20 Appeals 21 When certificates of unfitness take effect 22 Regulations for this Part PART V CONTROL OF PRESCRIPTIONS AND IMPORTATION 23 Prescriptions to be in a certain form 23A Validity of a prescription 24 Supply by registered pharmacist of equivalent medicines 25 Restrictions on the importation of medicines 26 Declaration relating to imported medicines [repealed] PART VI CONTROL OF DRUGS 27 Certain substances to be sold on prescription
    [Show full text]